Lemongrass inhaler shows promise for nicotine addiction
NCT ID NCT07366294
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether inhaling lemongrass (as a vapor or from an inhaler) could reduce nicotine dependence and improve health markers in 200 adult smokers aged 18–30. Participants used lemongrass products or nothing (control) and provided blood samples and questionnaires. The goal was to see if this natural approach could lower cravings, cotinine levels, and stress while improving sleep and fitness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- lemongrass (Cymbopogon citratus) inhaler and liquid vapor
- What this could lead to
- If it works, this could offer a natural, non-drug aid to help smokers cut down or quit, while also improving sleep and stress.
- What could go wrong
- This is a small, completed trial with no phase designation, so results may not be conclusive or generalizable. The effect may be weak or no better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
200 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 to 30 years * Current cigarette smokers reporting consumption of ≥5 cigarettes per day * Moderate to high nicotine dependence, defined as a Fagerström Test for Nicotine Dependence (FTND) score≥5 * Members of the academic community of the Faculty of Health Sciences, Universitas Brawijaya, Malang, East Java, Indonesia * Willing and able to provide informed consent and comply with study procedures Exclusion Criteria: * Current use of smoking cessation medications * History of lemongrass allergy * Presence of chronic respiratory conditions * History of severe cardiovascular disease * History of severe psychiatric disorders * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cigarette smoking are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Brawijaya
Malang, East Java, 65145, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Nicotine flux: a new way to gauge how addictive E-Cigarettes are?
- Can a Phone-Based sleep program help dementia caregivers rest better?
- Can a WhatsApp message help smokers quit?
- Can a sensor under the mattress match a sleep lab?
- Can a personalized mix of nerve stimulation and therapy rewire the brain for better mental health?